RGRajiv Gulati

Rajiv Gulati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rajiv Gulati has a total of 274 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Classification and Outcomes of Coronary Microvascular Disease in Myocardial Infarction and Angina With Nonobstructive Coronary Arteries

    by Justin G. Carrington, Kai Nogami, Yoshihisa Kanaji, Brad R. Lewis, Amr O. Moustafa, Rajiv Gulati, Marysia S. Tweet, Vassilis Vassiliou, Abhiram Prasad, Amir Lerman, et al.

    BACKGROUND: Myocardial infarction with nonobstructive coronary arteries (MINOCAs) and angina with nonobstructive coronary arteries (ANOCAs) present diagnostic and therapeutic challenges. We assessed the frequency of coronary microvascular disease (CMD) and its subtypes in MINOCA compared with ANOCA and evaluated long-term cardiovascular outcomes. METHODS: Patients with nonobstructive coronary arteries undergoing invasive coronary function testing from 2012 to 2022 were prospectively enrolled and retrospectively classified as MINOCA or ANOCA (reference group). Myocardial infarction due to atherothrombosis, myocarditis, and Takotsubo syndrome were excluded. Invasive provocation testing was performed. CMD was classified as endothelium-independent (coronary flow reserve P =0.271), while endothelium-independent CMD was more frequent in MINOCA (41% versus 21%; P P =0.001). CMD predicted higher major adverse cardiovascular events in both MINOCA (hazard ratio, 3.6 [95% CI, 1.1–12.0]; P =0.038) and ANOCA (hazard ratio, 7.9 [95% CI, 2.9–21.8]; P <0.001). CONCLUSIONS: CMD is common in both MINOCA and ANOCA. The higher prevalence of endothelium-independent CMD in MINOCA suggests a potential mechanistic role in infarction. Patients with MINOCA have a worse prognosis than ANOCA, particularly when CMD is present.

  • Temporal Trends and Predictors of Access Site Crossover During PCI in Contemporary Practice: A Report From the NCDR CathPCI Registry

    by Eli Reynolds, Binita Shah, Angel Marks, Daniel Wojdyla, Nathaniel R. Smilowitz, Jennifer Rymer, Ian C. Gilchrist, Rajiv Gulati, Sunil V. Rao

    BACKGROUND: Randomized trials comparing radial and femoral access report access site crossover rates of 3% to 9% for radial access and 1% to 3% for femoral access. However, contemporary real-world crossover rates are not well characterized. The aim was to evaluate contemporary trends and predictors of vascular access site crossover during percutaneous coronary intervention (PCI). METHODS: We analyzed index PCI procedures recorded in the National Cardiovascular Data Registry CathPCI (Catheterization and Percutaneous Coronary Intervention) Registry from 2018 to 2024. Access site crossover was identified using documented access data, with radial-to-femoral crossover inferred when the final successful access site was femoral. Temporal trends and clinical predictors of crossover were examined. Operator experience was assessed using cumulative total and radial PCI volumes from 2011 to 2024 as captured in CathPCI Registry versions 4 and 5. RESULTS: Among 3 861 790 index PCIs, 192 902 (5.0%) involved access site crossover, with a modest increase over time. Radial-to-femoral crossover accounted for 81.2% of crossover events. Factors independently associated with crossover included older age, female sex, higher body mass index, and peripheral vascular disease. Operators with the lowest total PCI volume and the lowest radial PCI volume experienced the highest crossover rates. Notably, operators with low radial PCI volume demonstrated a substantial decline in radial-to-femoral crossover over the study period. CONCLUSIONS: In contemporary clinical practice, access site crossover rates are consistent with those reported in randomized trials. Although crossover occurs more frequently among lower-volume operators, rates decline with increasing operator experience, supporting the presence of a radial access learning curve and improvement in procedural performance over time.


  • Open Access

    Extraction of Protruding Ostial Stents to Enable Percutaneous Coronary Interventions

    by Abdullah Al-Abcha, Emily Cendrowski, Claire E. Raphael, Mohamad Alkhouli, Abhiram Prasad, Malcolm R. Bell, Rajiv Gulati

  • Causes of Myocardial Infarction in Younger Patients

    by Claire E. Raphael, Yader Sandoval, Joel D. Beachey, Veronique Roger, Mandeep Singh, Matthew P. Johnson, Marysia S. Tweet, Malcolm R. Bell, Amir Lerman, Sharonne N. Hayes, et al.


  • Open Access

    Optical Coherence Tomography for Spontaneous Coronary Artery Dissection Assessment

    by Abdullah Al-Abcha, Trevor Simard, Marysia S. Tweet, Abhiram Prasad, Mohamad Alkhouli, Malcolm R. Bell, Rajiv Gulati


  • Novel Treatment of Left Main Bifurcation Aneurysm With Intrasaccular Flow Disruptor

    by Conor M. Lane, Waleed Brinjikji, Jason H. Anderson, Rajiv Gulati

  • Open Access

    Role of Biological Age in the Determination of Long‐Term Cause‐Specific Death Following Percutaneous Coronary Interventions

    by Mandeep Singh, Paul A. Friedman, Rajiv Gulati, Abdallah El Sabbagh, Bradley R. Lewis, Amrit Kanwar, Claire E. Raphael, Mohammed A. Al‐Hijji, Zachi I. Attia, Atta Behfar, et al.

    Background: We tested whether biologic age, as estimated by deficits, functional impairments, or Age‐Gap or their combination, provide improved estimation of cause‐specific death as compared with chronological age. Methods: Cardiovascular and noncardiovascular deficits, functional impairments, and Age‐Gap were prospectively collected in 535 patients aged ≥55 years undergoing percutaneous coronary interventions between August 1, 2014, and March 31, 2018. Age‐Gap was calculated as the difference between chronological age and age estimated by artificial intelligence ECG using a convolutional neural network. The full biological age model included deficits, functional impairments, and Age‐Gap >2 SD. A multivariable reduced model with the least number of variables was also created to provide a comparable C index to the full model. Results: The average chronological age was 72.1±9.5 years, and there were 68% of men. During a median follow‐up of 2.61 years, 124 (23%) patients died. There was a modest correlation between Age‐Gap and biological age ( r =0.28 [95% CI, 0.20–0.35]; P P P <0.001) mortality. As compared with chronological age, the full biological age model noted significant improvement in the prediction of long‐term overall (95% CI, 0.65–0.78), cardiovascular (95% CI, 0.69–0.77), and noncardiovascular (95% CI, 0.55–0.86) mortality. In the reduced models, most prognostic information for noncardiovascular mortality (C index: 0.79) was obtained by subjective difficulty in performing tasks, whereas the deficit‐based estimation predicted cardiovascular mortality (C index: 0.72). Conclusions: Estimated biological age from deficits and functional impairments was superior to chronological age in predicting long‐term cause‐specific mortality following percutaneous coronary interventions.


  • Open Access

    Virtual Reality Simulation With Integrated Passive Haptics Prototype for Cardiac Catheterization Laboratory Training

    by Garrett A. Welle, Jack R. Miller, Abdullah Al-Abcha, Ana Ehtemami, Jonathan M. Morris, Mohamad Alkhouli, Benjamin Hibbert, Rajiv Gulati, Abhiram Prasad, Trevor Simard

  • Open Access

    Thirty-Day High-Grade Aortic Valve Block Post-Transcatheter Aortic Valve Replacement in Patients Discharged on Heart Rhythm Monitor

    by Mohamad S. Alabdaljabar, Mohamed Elhadi, Rajiv Gulati, Charanjit S. Rihal, Paul A. Friedman, Yong-Mei Cha, Mackram F. Eleid


  • Open Access

    Patients With Coronary Microvascular Dysfunction Have Less Circulating α‐Klotho

    by Nadia Akhiyat, Ilke Ozcan, Rajiv Gulati, Abhiram Prasad, Tamara Tchkonia, James L. Kirkland, Bradley Lewis, Lilach O. Lerman, Amir Lerman

    Background: Coronary microvascular dysfunction (CMD) represents an early functional characteristic of coronary vascular aging. Klotho (α‐klotho) is a circulating protein inversely linked to physiological aging. We examined low klotho as a potential marker for vascular aging in patients with CMD and no coronary artery disease. Methods and Results: Patients undergoing nonurgent angiogram for chest pain who had no coronary artery disease underwent invasive coronary microvascular and endothelial function testing. CMD was defined by ≤50% increase in coronary blood flow (percentage change in coronary blood flow) in response to intracoronary acetylcholine or coronary flow reserve ≤2. Fresh arterial whole blood was used to analyze circulating endothelial progenitor cells with flow cytometry. Stored arterial plasma was used for klotho analysis by ELISA. Participants with CMD (n=62) were compared with those without CMD (n=36). Those with CMD were age 55±10 years (versus 51±11 years; P =0.07) and 73% women (versus 81%; P =0.38). Traditional risk factors for coronary artery disease were similar between groups. Patients with CMD had less klotho (0.88±1.50 versus 1.75±2.38 ng/mL; P =0.03), and the odds of low klotho in CMD were significant in a logistic regression model after adjusting for traditional cardiovascular risk factors (odds ratio [OR], 0.80 [95% CI, 0.636–0.996]; P =0.05). Higher klotho was associated with higher numbers of endothelial progenitor cells with vascular regenerative potential (CD34 + and CD34 + CD133 + KDR + ). Among a subgroup of patients with atherosclerotic cardiovascular disease risk P =0.047). Conclusions: Klotho may be a biomarker for CMD and may be a therapeutic target for groups of patients without significant traditional cardiovascular risk.